A primary undifferentiated pleomorphic sarcoma of the lumbosacral region harboring a LMNA-NTRK1 gene fusion with durable clinical response to crizotinib: a case report

Overview of attention for article published in BMC Cancer, August 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 21 Dimensions

Readers on

mendeley: 23 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Methods of treating cholangiocarcinoma

Grant US-11771698-B2

United States of America

NTRK1 fusion molecules and uses thereof

Grant US-11578372-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.